Nova Clinical Research Support Shawnee Mission, KS - 66221

Nova Clinical Research Support is categorized under Medical Labs in Shawnee Mission, KS and active since 2004.

Nova Clinical Research Support was established in 2004, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 4461100 by the NAICS.

If you are seeking more information, feel free to contact Richard Angelo, Owner at the company’s single location by writing to 13730 Cody St, Shawnee Mission, Kansas KS 66221 or by phoning (913) 402-4520. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Nova Clinical Research Support
Contact Person: Richard Angelo, Owner
Address: 13730 Cody St, Shawnee Mission, Kansas 66221
Phone Number: (913) 402-4520
Website Address: novacrs.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2004
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Medical Labs
SIC Code: 8071
NAICS Code: 4461100
Share This Business:

Nova Clinical Research Support was started in 2004 to provide professional Medical Labs under the SIC code 8071 and NAICS code 4461100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Richard Angelo, Owner for inquiries that concern Nova Clinical Research Support by calling the company number (913) 402-4520, as your correspondence is most welcome. Additionally, the physical location of the single location of Nova Clinical Research Support can be found at the coordinates 38.878777,-94.722133 as well as the street address 13730 Cody St in Shawnee Mission, Kansas 66221.

For its online presence, you may visit Nova Clinical Research Support’s website at novacrs.com and engage with its social media outlets through on Twitter and on Facebook.